Larotrectinib

Pediatric Oncology Long-term Efficacy and Safety of Larotrectinib in Pediatric Patients with Primary CNS and Non-Primary CNS TRK Fusion Tumors
Omar Chamdine • Leo Mascarenhas • François Doz • Birgit Geoerger • Steven G. DuBois • Sébastien Perreault • Christian Michel Zwaan • Catherine M. Albert • Claudia Blattman • Anna Nilsson • Rejin Kebudi • Karsten Nysom • Vadim Bernard-Gauthier • Esther De La Cuesta • Natascha Neu • Theodore W. Laetsch • Yizhuo Zhang • Cornelis M. van Tilburg
doi.org/10.69690/ODMJ-018-0425-879